[GlobeNewswire] - MOUNTAIN VIEW, Calif. -- ChemoCentryx, Inc. announced today that it has priced an underwritten public offering of an aggregate of 5,000,000 shares of its common stock at a price to the public of $12.00 ...
You are receiving this email because you subscribed to this feed at blogtrottr.com.
No comments:
Post a Comment